MPPW
VRTX icon

Mitchell & Pahl Private Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Mitchell & Pahl Private Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$998K Hold
2,009
– – 0.37% 91
2026
Q1 		$897K Sell
2,009
-40
-2% -$18.7K 0.36% 96
2025
Q4 		$929K Sell
2,049
-95
-4% -$40.9K 0.39% 93
2025
Q3 		$840K Hold
2,144
– – 0.35% 100
2025
Q2 		$955K Sell
2,144
-5
-0.2% -$2.3K 0.42% 82
2025
Q1 		$1.04M Hold
2,149
– – 0.49% 74
2024
Q4 		$865K Sell
2,149
-30
-1% -$13.9K 0.4% 87
2024
Q3 		$1.01M Sell
2,179
-4
-0.2% -$1.92K 0.47% 82
2024
Q2 		$1.02M Sell
2,183
-29
-1% -$12.6K 0.54% 74
2024
Q1 		$925K Sell
2,212
-5
-0.2% -$2.11K 0.49% 75
2023
Q4 		$902K Sell
2,217
-13
-0.6% -$4.8K 0.51% 73
2023
Q3 		$775K Sell
2,230
-42
-2% -$14.7K 0.46% 78
2023
Q2 		$800K Sell
2,272
-1
-0% -$337 0.48% 73
2023
Q1 		$716K Sell
2,273
-8
-0.4% -$2.4K 0.45% 81
2022
Q4 		$659K Sell
2,281
-288
-11% -$87.8K 0.43% 83
2022
Q3 		$744K Sell
2,569
-53
-2% -$15.2K 0.55% 69
2022
Q2 		$739K Sell
2,622
-155
-6% -$41.5K 0.51% 74
2022
Q1 		$725K Sell
2,777
-28
-1% -$6.64K 0.46% 78
2021
Q4 		$616K Sell
2,805
-262
-9% -$50.9K 0.39% 85
2021
Q3 		$556K Sell
3,067
-20
-0.6% -$3.9K 0.4% 82
2021
Q2 		$622K Sell
3,087
-9
-0.3% -$1.88K 0.44% 78
2021
Q1 		$665K Sell
3,096
-13
-0.4% -$2.85K 0.52% 69
2020
Q4 		$735K Buy
+3,109
New +$713K 0.62% 53

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Mitchell & Pahl Private Wealth's VRTX Position: Q2 2026 in Review

Mitchell & Pahl Private Wealth held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 2,009 shares worth $998K. The position accounts for 0.37% of the portfolio, ranked #91.

Mitchell & Pahl Private Wealth first reported a position in VRTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.04M in Q1 2025. 302 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Mitchell & Pahl Private Wealth held 2,009 shares of Vertex Pharmaceuticals worth $998K as of Q2 2026.
  • Mitchell & Pahl Private Wealth left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.37% of Mitchell & Pahl Private Wealth's portfolio in Q2 2026, its #91 holding.
  • Mitchell & Pahl Private Wealth first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Mitchell & Pahl Private Wealth's Vertex Pharmaceuticals position peaked at $1.04M in Q1 2025.
  • 302 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Mitchell & Pahl Private Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.